Appropriate intraprocedural initial heparin dosing in patients undergoing catheter ablation for atrial fibrillation receiving uninterrupted non-vitamin-K antagonist oral anticoagulant treatment

BACKGROUND: To clarify the appropriate initial dosage of heparin during radiofrequency catheter ablation (RFCA) in patients with atrial fibrillation (AF) receiving uninterrupted nonvitamin K antagonist oral anticoagulant (NOAC) treatment. METHODS: A total of 187 consecutive AF patients who underwent...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Rong-feng, Ma, Cheng-ming, Wang, Na, Yang, Ming-hui, Li, Wen-wen, Yin, Xiao-meng, Dong, Ying-xue, Yu, Xiao-hong, Xiao, Xian-jie, Xia, Yun-long, Gao, Lian-jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077881/
https://www.ncbi.nlm.nih.gov/pubmed/33906609
http://dx.doi.org/10.1186/s12872-021-02032-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077881/
https://www.ncbi.nlm.nih.gov/pubmed/33906609
http://dx.doi.org/10.1186/s12872-021-02032-3

Ejemplares similares